These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10374704)

  • 21. Effectivity of heparin in assisted reproduction.
    Fiedler K; Würfel W
    Eur J Med Res; 2004 Apr; 9(4):207-14. PubMed ID: 15210401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study.
    Song Y; Wang HY; Qiao J; Liu P; Chi HB
    Chin Med J (Engl); 2017 Feb; 130(3):267-272. PubMed ID: 28139508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune factors in assisted reproduction.
    Kutteh WH
    Minerva Ginecol; 2002 Jun; 54(3):217-24. PubMed ID: 12063437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiphospholipid antibodies and pregnancy.
    Costa M; Rossi E
    Ann N Y Acad Sci; 1999 Jun; 876():383-6. PubMed ID: 10415632
    [No Abstract]   [Full Text] [Related]  

  • 25. Meta-analysis of heparin combined with aspirin versus aspirin alone for unexplained recurrent spontaneous abortion.
    Li J; Gao YH; Xu L; Li ZY
    Int J Gynaecol Obstet; 2020 Oct; 151(1):23-32. PubMed ID: 32535924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).
    Hoppe B; Burmester GR; Dörner T
    Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of recurrent spontaneous abortion associated with the antiphospholipid antibody syndrome].
    Carbonne B; Lejeune V
    Gynecol Obstet Fertil; 2003 Sep; 31(9):789-93. PubMed ID: 14499730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
    Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
    Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunotherapy as an effective treatment of recurrent spontaneous abortion--own experience].
    Jerzak M; Rechberger T; Baranowski W; Semczuk M
    Ginekol Pol; 2003 Oct; 74(10):1107-11. PubMed ID: 14669403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy for recurrent pregnancy loss: "standard of care or buyer beware".
    Hill JA
    J Soc Gynecol Investig; 1997; 4(6):267-73. PubMed ID: 9408880
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
    Rai R; Cohen H; Dave M; Regan L
    BMJ; 1997 Jan; 314(7076):253-7. PubMed ID: 9022487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
    Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Low dose of aspirin during pregnancy].
    Aguilera C; Agustí A
    Med Clin (Barc); 2007 Jan; 128(1):31-3. PubMed ID: 17266890
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages.
    Jeremić K; Pervulov M; Gojnić M; Dukanac J; Ljubić A; Stojnić J
    Vojnosanit Pregl; 2005 Jun; 62(6):435-9. PubMed ID: 16047856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of aspirin plus heparin with heparin alone on asymptomatic perioperative deep vein thrombosis in candidates for elective off-pump coronary artery bypass graft: a randomized clinical trial.
    Mirhosseini SJ; Forouzannia SK; Mostafavi Pour Manshadi SM; Ali-Hasan-Al-Saegh S; Naderi N; Sanatkar M
    Cardiol J; 2013; 20(2):139-43. PubMed ID: 23558871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease.
    North RA; Ferrier C; Gamble G; Fairley KF; Kincaid-Smith P
    Aust N Z J Obstet Gynaecol; 1995 Nov; 35(4):357-62. PubMed ID: 8717553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion.
    Pandey MK; Agrawal S
    Int Immunopharmacol; 2004 Feb; 4(2):289-98. PubMed ID: 14996420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin/aspirin therapy for implantation failure in IVF cycles.
    Prakash A; Ola B
    Fertil Steril; 2004 May; 81(5):1431; author reply 1431-2. PubMed ID: 15136130
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.